These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Villoglandular adenocarcinoma of the endometrium. Ambros RA; Malfetano JH Am J Surg Pathol; 2000 Jan; 24(1):155-6. PubMed ID: 10632501 [No Abstract] [Full Text] [Related]
43. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma]. Wen HW; Zhang LD Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370 [TBL] [Abstract][Full Text] [Related]
44. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498 [TBL] [Abstract][Full Text] [Related]
45. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Fleming ND; Lentz SE; Cass I; Li AJ; Karlan BY; Walsh CS Gynecol Oncol; 2011 Feb; 120(2):189-92. PubMed ID: 21112078 [TBL] [Abstract][Full Text] [Related]
46. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases. Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268 [TBL] [Abstract][Full Text] [Related]
48. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature. Mariño-Enríquez A; González-Rocha T; Burgos E; Stolnicu S; Mendiola M; Nogales FF; Hardisson D Hum Pathol; 2008 Nov; 39(11):1606-13. PubMed ID: 18620731 [TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959 [TBL] [Abstract][Full Text] [Related]
50. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis. Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159 [TBL] [Abstract][Full Text] [Related]
51. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Powell MA; Mutch DG; Rader JS; Herzog TJ; Huang TH; Goodfellow PJ Cancer; 2002 Jun; 94(11):2941-52. PubMed ID: 12115383 [TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Stefansson IM; Salvesen HB; Immervoll H; Akslen LA Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995 [TBL] [Abstract][Full Text] [Related]
53. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Hirai M; Nakagawara A; Oosaki T; Hayashi Y; Hirono M; Yoshihara T Gynecol Oncol; 2001 Feb; 80(2):181-8. PubMed ID: 11161857 [TBL] [Abstract][Full Text] [Related]
54. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071 [TBL] [Abstract][Full Text] [Related]
55. Utility of liquid-based cytology in endometrial pathology: diagnosis of endometrial carcinoma. Norimatsu Y; Kouda H; Kobayashi TK; Shimizu K; Yanoh K; Tsukayama C; Miyake Y; Ohno E Cytopathology; 2009 Dec; 20(6):395-402. PubMed ID: 19863617 [TBL] [Abstract][Full Text] [Related]
56. [Prognostic significance of diagnostic delay in carcinoma of the endometrium: our experience]. Garzetti GG; Ciavattini A; Cignitti M; Lufino R; Romanini C Ann Ostet Ginecol Med Perinat; 1992; 113(1):55-9. PubMed ID: 1476403 [TBL] [Abstract][Full Text] [Related]
57. [Synchronous primary cancer of the endometrium and ovary]. Lou HM; Lou HK; Wu MJ Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):617-20. PubMed ID: 17236559 [TBL] [Abstract][Full Text] [Related]
58. Relationship between angiogenesis and grade of histologic differentiation in endometrial adenocarcinoma. de Góis Speck NM; Focchi J; Alves AC; Ribalta JC; Osório CA Eur J Gynaecol Oncol; 2005; 26(6):599-601. PubMed ID: 16398216 [TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic analysis: relationship between endometrial carcinoma and uninvolved endometrium. Dane C; Tatar Z; Dane B; Cetin A Eur J Gynaecol Oncol; 2009; 30(1):71-4. PubMed ID: 19317261 [TBL] [Abstract][Full Text] [Related]
60. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Lee KR; Vacek PM; Belinson JL Gynecol Oncol; 1994 Jul; 54(1):10-8. PubMed ID: 8020830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]